Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.16%) 5 335.75 points
Dow Jones Futures
(0.07%) 40 167 points
Nasdaq Futures
(0.24%) 18 680 points
Oil
(-0.57%) $79.60
Gas
(1.37%) $2.66
Gold
(0.55%) $2 430.80
Silver
(0.79%) $31.51
Platinum
(-1.30%) $1 075.80
USD/EUR
(0.12%) $0.921
USD/NOK
(0.19%) $10.70
USD/GBP
(0.09%) $0.788
USD/RUB
(-0.31%) $90.69

Realtime updates for Ascelia Pharma AB (publ) [ACE.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated20 May 2024 @ 08:16
25% discount on Stockinvest.us - Use code: Podcast

-2.48% SEK 9.05

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 08:16):

Ascelia Pharma AB (publ), a biotech company, operates as an oncology-focused orphan drug development company in Sweden. It is developing Mangoral, a novel non-gadolinium contrast agent, which is in Phase 3 for use in MRI-scans of the liver; and Oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer...

Stats
Today's Volume 300 513
Average Volume 273 766
Market Cap 305.51M
EPS SEK0 ( 2024-05-15 )
Next earnings date ( SEK-0.400 ) 2024-08-14
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -2.79
ATR14 SEK0.0440 (0.49%)

Volume Correlation

Long: 0.10 (neutral)
Short: 0.33 (neutral)
Signal:(51.665) Neutral

Ascelia Pharma AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ascelia Pharma AB (publ) Correlation - Currency/Commodity

The country flag -0.19
( neutral )
The country flag -0.05
( neutral )
The country flag 0.00
( neutral )
The country flag -0.31
( neutral )
The country flag 0.64
( weak )
The country flag 0.30
( neutral )

Ascelia Pharma AB (publ) Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK-1.05M (0.00 %)
EPS: SEK-3.24
FY 2023
Revenue: SEK0
Gross Profit: SEK-1.05M (0.00 %)
EPS: SEK-3.24
FY 2022
Revenue: SEK0
Gross Profit: SEK-3.89M (0.00 %)
EPS: SEK-3.90
FY 2021
Revenue: SEK0.00
Gross Profit: SEK-8.72M (0.00 %)
EPS: SEK-1.200

Financial Reports:

No articles found.

Ascelia Pharma AB (publ) Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ascelia Pharma AB (publ)

Ascelia Pharma AB (publ), a biotech company, operates as an oncology-focused orphan drug development company in Sweden. It is developing Mangoral, a novel non-gadolinium contrast agent, which is in Phase 3 for use in MRI-scans of the liver; and Oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer. It has a clinical collaboration agreement with Taiho Oncology, Inc. for the development of Oncoral in combination with LONSURF. Ascelia Pharma AB (publ) was founded in 2000 and is headquartered in Malmö, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators